U.S. Biliary Stents Market by Type (Metal Biliary stents, and Plastic Biliary stents), Application (Malignant Obstruction, Benign Biliary Strictures, Biliary Leaks, and Others), and End User (Hospitals, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025

March 2019 | 100 pages | ID: U17A7FD7462EN
Allied Market Research

Abstracts

The U.S. biliary stents market was valued at $316 million in 2017 and is expected to reach $474 million by 2025, growing at a CAGR of 5.2% from 2018 to 2025. A biliary metal stent also known as a bile duct stent is a flexible metallic tube specifically designed to open a patient’s bile duct that has been blocked or partially blocked. A biliary stent is inserted to reduce or eliminate the blockage. Once it is in place in the obstructed part, the stent expands and opens the channel so that fluids can continue to move to the intestine. Metallic stents are generally made with cobalt-chromium (stainless steel) or an alloy, including nickel-titanium (nitinol), which is a shape memory alloy.

The significant rise in the prevalence of pancreatic cancer and other biliary diseases across the U.S. is one of the major factors that drives the biliary stents market. For instance, according to the American Cancer Society (2019), pancreatic cancer accounts for about 3% of all cancers in the U.S. and about 7% of all cancer deaths. In addition, technological advancements associated with biliary stents and surge in demand for minimally invasive procedures further contributes to the market growth.

Although the U.S. biliary stents market continues to grow, certain factors hamper the growth of this market. The complications and high costs associated with biliary stents are anticipated to hamper the market growth. Conversely, development of innovative smartphone applications leading to better adoption and opportunities in the emerging economies are anticipated to offer growth opportunities for the U.S. biliary stents market.

The U.S. biliary stent market is segmented based on type, application, and end user. Based on type, it is categorized into biliary metal stents, and biliary plastic stents. Based on application, the market is categorized into malignant obstruction, benign biliary strictures, biliary leaks, and others. Based on end user, it is divided into hospitals and ambulatory surgical centers. The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Conmed Corporation, Cook Medical, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Merit Medical, Olympus Corporation, and Becton, Dickinson and Company. The other players included in the value chain analysis (but not included in the report) are Taewoong Medical Co., Ltd., Biosensors International Group, Ltd., and others.

Key Benefits for Stakeholders

• The report provides an extensive analysis of the current market trends and future estimations of the U.S. biliary stents market.
• The U.S. biliary stents market top player positioning is comprehensively analyzed in the report.
• The U.S. biliary stents market share is comprehensively analyzed with respect to the application, type, and end user.
• U.S. biliary market growth analysis by type helps understand the significance of the different types of biliary stents available in the market.
• Key manufacturers involved in the U.S. biliary stents market are listed and analyzed in this report to understand the competitive scenario of the market.

Key Market Segments

• By Type
• Metal biliary stents
• Plastic biliary stents
• By Application
• Malignant obstruction
• Benign biliary strictures
• Biliary leaks
• Others
• By End User
• Hospitals
• Ambulatory surgical centers

Contents

CHAPTER: 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
  1.3.1. List of players profiled in the report
1.4. Research Methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER: 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO perspective

CHAPTER: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porter’s five forces analysis
3.5. Market dynamics
  3.5.1. Drivers
    3.5.1.1. High prevalence of biliary diseases
    3.5.1.2. Technological advancements associated with biliary stents and urge in demand for minimally invasive procedures
  3.5.2. Restraint
    3.5.2.1. Complications and high costs associated with biliary stents
  3.5.3. Opportunity
    3.5.3.1. Development of innovative smartphone applications

CHAPTER: 4: U.S. BILIARY STENTS MARKET, BY TYPE

4.1. Overview
  4.1.1. Market size and forecast
4.2. Metal Biliary Stents
  4.2.1. Key market trends, growth factors, and opportunities
  4.2.2. Market size and forecast
4.3. Plastic Biliary Stents
  4.3.1. Key market trends, growth factors, and opportunities
  4.3.2. Market size and forecast

CHAPTER: 5: U.S. BILIARY STENTS MARKET, BY APPLICATION

5.1. Overview
  5.1.1. Market size and forecast
5.2. Malignant obstruction
  5.2.1. Market size and forecast
5.3. Benign biliary strictures
  5.3.1. Market size and forecast
5.4. Biliary leaks
  5.4.1. Market size and forecast
5.5. Others
  5.5.1. Market size and forecast

CHAPTER: 6: U.S. BILIARY STENTS MARKET, BY END USER

6.1. Overview
  6.1.1. Market size and forecast
6.2. Hospitals
  6.2.1. Market size and forecast
6.3. Ambulatory surgical centers
  6.3.1. Market size and forecast

CHAPTER: 7: COMPANY PROFILES

7.1. ABBOTT LABORATORIES
  7.1.1. Company overview
  7.1.2. Company snapshot
  7.1.3. Operating business segments
  7.1.4. Product portfolio
  7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Product portfolio
  7.2.5. Business performance
7.3. BECTON, DICKINSON AND COMPANY
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Product portfolio
  7.3.5. Business performance
7.4. BOSTON SCIENTIFIC CORPORATION
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Product Portfolio
  7.4.5. Business performance
7.5. COOK MEDICAL INC.
  7.5.1. Company overview
  7.5.2. Company snapshot
  7.5.3. Operating business segments
  7.5.4. Product portfolio
7.6. CONMED CORPORATION
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Business performance
  7.6.5. Product portfolio
7.7. MEDTRONIC PLC
  7.7.1. Company overview
  7.7.2. Company snapshot
  7.7.3. Operating business segments
  7.7.4. Product portfolio
  7.7.5. Business performance
7.8. MERIT MEDICAL SYSTEMS, INC.
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Product portfolio
  7.8.5. Business performance
7.9. OLYMPUS CORPORATION
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Product Portfolio
  7.9.5. Business performance
7.10. TERUMO MEDICAL CORPORATION
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating business segments
  7.10.4. Product portfolio
  7.10.5. Business performance

List Of Tables

LIST OF TABLES

TABLE 01. U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 02. U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 03. U.S. BILIARY STENTS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 04. ABBOTT: COMPANY SNAPSHOT
TABLE 05. ABBOTT: OPERATING SEGMENTS
TABLE 06. ABBOTT: PRODUCT PORTFOLIO
TABLE 07. B. BRAUN: COMPANY SNAPSHOT
TABLE 08. B. BRAUN: OPERATING SEGMENTS
TABLE 09. B. BRAUN: PRODUCT PORTFOLIO
TABLE 10. BD: COMPANY SNAPSHOT
TABLE 11. BD: OPERATING SEGMENTS
TABLE 12. B. BRAUN: PRODUCT PORTFOLIO
TABLE 13. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 14. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 15. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 16. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 17. COOK MEDICAL: OPERATING SEGMENTS
TABLE 18. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 19. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 20. CONMED CORPORATION: OPERATING SEGMENTS
TABLE 21. CONMED: PRODUCT PORTFOLIO
TABLE 22. MEDTRONIC: COMPANY SNAPSHOT
TABLE 23. MEDTRONIC: OPERATING SEGMENTS
TABLE 24. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 25. MERIT: COMPANY SNAPSHOT
TABLE 26. MERIT: OPERATING SEGMENTS
TABLE 27. MERIT: PRODUCT PORTFOLIO
TABLE 28. OLYMPUS CORPORATION.: COMPANY SNAPSHOT
TABLE 29. OLYMPUS CORPORATION.: OPERATING SEGMENTS
TABLE 30. OLYMPUS CORPORATION.: PRODUCT PORTFOLIO
TABLE 31. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 32. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 33. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO

List Of Figures

LIST OF FIGURES

FIGURE 01. U.S. BILIARY STENTS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. LOW BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. HIGH COMPETITIVE RIVALRY
FIGURE 09. MARKET DRIVERS, RESTRAINT, AND OPPORTUNITY
FIGURE 10. U.S. BILIARY STENTS MARKET FOR METAL BILIARY STENTS, 2017–2025 ($MILLION)
FIGURE 11. U.S. BILIARY STENTS MARKET FOR PLASTIC BILIARY STENTS, 2017–2025 ($MILLION)
FIGURE 12. U.S. BILIARY STENTS MARKET FOR MALIGNANT OBSTRUCTION, 2017-2025 ($MILLION)
FIGURE 13. U.S. BILIARY STENTS MARKET FOR BENIGN BILIARY STRICTURES, 2017-2025 ($MILLION)
FIGURE 14. U.S. BILIARY STENTS MARKET FOR BELIARY LEAKS, 2017-2025 ($MILLION)
FIGURE 15. U.S. BILIARY STENTS MARKET FOR OTHERS, 2017-2025 ($MILLION)
FIGURE 16. U.S. BILIARY STENTS MARKET FOR HOSPITALS, 2017-2025 ($MILLION)
FIGURE 17. U.S. BILIARY STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, 2017-2025 ($MILLION)
FIGURE 18. ABBOTT: NET SALES, 2015–2017 ($MILLION)
FIGURE 19. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 20. ABBOTT: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 21. B. BRAUN: NET SALES, 2015–2017($MILLION)
FIGURE 22. B. BRAUN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 23. B. BRAUN: REVENUE SHARE BY REGION, 2017(%)
FIGURE 24. BD: NET SALES, 2015–2017 ($MILLION)
FIGURE 25. BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 26. BD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 27. BOSTON SCIENTIFIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 28. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 29. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 30. CONMED CORPORATION.: REVENUE, 2015–2017 ($MILLION)
FIGURE 31. CONMED CORPORATION.: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
FIGURE 32. CONMED CORPORATION: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 33. MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 34. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 35. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 36. MERIT: NET SALES, 2014–2016 ($MILLION)
FIGURE 37. MERIT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. MERIT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39. OLYMPUS CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 40. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42. TERUMO MEDICAL CORPORATION: NET SALES, 2015–2017 ($MILLION)
FIGURE 43. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)